Brain & Muscle Stimulation for Stroke Rehabilitation
Trial Summary
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using medications that lower the seizure threshold, as decided by the study physician.
Research shows that transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique, is associated with significant motor function improvement in stroke patients, especially when used in repeated sessions.
12345Transcranial direct current stimulation (tDCS) is generally considered safe for humans when used at an intensity of 4 mA or less for up to 60 minutes per day, with no severe complications reported in over 33,200 sessions. However, it can cause mild skin irritation, and caution is advised for potentially vulnerable groups like children and the elderly.
678910This treatment uses transcranial direct current stimulation (tDCS), a non-invasive method that applies a small electrical current to the brain to enhance motor recovery and improve daily living activities after a stroke, which is different from traditional physical therapies that do not involve direct brain stimulation.
511121314Eligibility Criteria
This trial is for stroke survivors over 21 years old with chronic upper limb hemiplegia, who can follow commands and have some finger movement. They must be medically stable, able to sit unassisted, and at least 6 months post-stroke. Excluded are pregnant individuals, those with other neurological conditions or severe pain in the affected limb, recent botox injections in the arm muscles, certain metal implants or electronic devices.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive non-invasive brain stimulation and neuromuscular electrical stimulation to improve hand motor control
Follow-up
Participants are monitored for safety and effectiveness after treatment
Participant Groups
electrical stimulator is already approved in United States, European Union for the following indications:
- Stroke rehabilitation
- Motor disorders
- Stroke rehabilitation
- Motor disorders